Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Marisa Dunigan"'
Autor:
Michael D. Kinnaman, Simone Zaccaria, Alvin Makohon-Moore, Brian Arnold, Max Levine, Gunes Gundem, Juan E. Arango Ossa, Dominik Glodzik, M. Irene Rodríguez-Sánchez, Nancy Bouvier, Shanita Li, Emily Stockfisch, Marisa Dunigan, Cassidy Cobbs, Umesh Bhanot, Daoqi You, Katelyn Mullen, Jerry Melchor, Michael V. Ortiz, Tara O’Donohue, Emily Slotkin, Leonard H. Wexler, Filemon S. Dela Cruz, Meera Hameed, Julia L. Glade Bender, William D. Tap, Paul A. Meyers, Elli Papaemmanuil, Andrew L. Kung, Christine A Iacobuzio-Donahue
Publikováno v:
bioRxiv
Multiple large-scale tumor genomic profiling efforts have been undertaken in osteosarcoma, however, little is known about the spatial and temporal intratumor heterogeneity and how it may drive treatment resistance. We performed whole-genome sequencin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::842580c63e2a605b39383fb19c2db973
https://doi.org/10.1101/2023.01.05.522765
https://doi.org/10.1101/2023.01.05.522765
Autor:
Ritesh R. Kotecha, Erika Gedvilaite, Ryan Ptashkin, Andrea Knezevic, Samuel Murray, Ian Johnson, Natalie Shapnik, Darren R. Feldman, Maria I. Carlo, Neil J. Shah, Marisa Dunigan, Kety Huberman, Ryma Benayed, Ahmet Zehir, Michael F. Berger, Marc Ladanyi, Dana W. Y. Tsui, Robert J. Motzer, Chung-Han Lee, Martin H. Voss
Publikováno v:
JCO Precis Oncol
PURPOSE The clinical utility of cell-free DNA (cfDNA) as a biomarker for advanced clear cell renal cell carcinoma (ccRCC) remains unclear. We evaluated the validity of cfDNA-based genomic profiling in a large cohort of patients with ccRCC with matche
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab5896cfdf9596b79c81636eb8a5d3be
https://doi.org/10.1200/po.22.00012
https://doi.org/10.1200/po.22.00012
